Rachel Humphrey Pyxis Oncology, Inc. (PYXS) insider trading activity

PYXS Quotes by TradingView

Rachel Humphrey is of Pyxis Oncology, Inc.. Currently has a direct ownership of 96,805 shares of PYXS, which is worth approximately $277,830. The most recent transaction as insider was on Mar 26, 2024, when has been sold 38,741 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 96.8K
0% 3M change
66.72% 12M change
Total Value Held $277,830

RACHEL HUMPHREY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 26 2024
BUY
Grant, award, or other acquisition
-
38,741 Added 28.58%
96,805 Common Stock
Mar 24 2023
BUY
Grant, award, or other acquisition
-
58,064 Added 50.0%
58,064 Common Stock

Also insider at

BDTX
Black Diamond Therapeutics, Inc. Healthcare
Chief Medical Officer
RH

Rachel Humphrey

Cambridge, MA

Track Institutional and Insider Activities on PYXS

Follow Pyxis Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PYXS shares.

Notify only if

Insider Trading

Get notified when an Pyxis Oncology, Inc. insider buys or sells PYXS shares.

Notify only if

News

Receive news related to Pyxis Oncology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PYXS